載入...
Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review
The clinical spectrum of prostate cancer (PCa) varies from castration-naive to metastatic castration-resistant disease. Despite the administration of androgen synthesis inhibitors and chemotherapy regimens for castration-resistant prostate cancer, the treatment options for this entity are limited. T...
Na minha lista:
| 發表在: | Int J Mol Sci |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7432105/ https://ncbi.nlm.nih.gov/pubmed/32751945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21155484 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|